Copyright: ©Author(s) 2026.
World J Hepatol. Mar 27, 2026; 18(3): 117465
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.117465
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.117465
Table 3 Newly developed fibrosis risk score system and its scoring scheme
| Parameter | Points | |
| Platelet count < 150 × 109/L | 5 | |
| AST > 45 U/L | 3 | |
| Serum albumin < 3.5 g/dL | 3 | |
| Total cholesterol < 140 mg/dL | 3 | |
| LDL < 80 mg/dL | 3 | |
| ALP > 75 U/L | 2 | |
| GGT > 40 U/L | 1 | |
| Interpretation of the score | ||
| Total score | Risk category | Interpretation |
| < 5 | Low risk | Minimal risk of significant fibrosis |
| ≥ 5 and < 9 | Intermediate risk | Borderline risk → further evaluation suggested |
| 9-20 | High risk | Strongly predictive of F2-F4 fibrosis |
- Citation: Bashir A, Arora R, Mehrotra D, Bala M, Parry AH, Iqball A, Bhat SA, Wani ZA. Non-invasive prediction of significant hepatic fibrosis in individuals with chronic hepatitis C infection using fibrosis risk score and machine learning models. World J Hepatol 2026; 18(3): 117465
- URL: https://www.wjgnet.com/1948-5182/full/v18/i3/117465.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i3.117465